ABSI - Healthcare Sector Review: Countercyclical or Carnage?

 

While investor attention remains firmly focused on technology, artificial intelligence and mining, the healthcare sector has largely fallen off the public radar. The S&P/ASX 200 Health Care Index (ASX: XHJ) has experienced a prolonged period of underperformance, with the recent decline proving particularly severe relative to other sector indices.

The magnitude of the sell-off has erased years of cumulative gains and pushed valuation and technical measures toward extreme levels. Although the precise drivers remain open to debate (deteriorating earnings expectations, constituent-specific challenges, structural headwinds, or investor sentiment), the extent of the underperformance warrants closer scrutiny.

Gain Access to the Full Desk Note

 

Investor Highlights

  • The Australian healthcare sector is approaching valuation and sentiment levels rarely seen over the past two decades.

  • A growing divergence between market pricing and underlying expectations has created one of the most interesting setups in recent years.

  • Recent sector performance has diverged significantly from both historical trends and comparable global healthcare indices.